Simultaneous acute cardio-cerebral infarction: is there a consensus for management?

Area of Science:

• Cardiology
• Neurology
• Emergency Medicine

Background:

• Acute ischemic stroke (AIS) and acute myocardial infarction (AMI) are critical emergencies with narrow therapeutic windows.
• Simultaneous presentation of AIS and AMI (cardio-cerebral infarction or CCI) poses unique and unclear management dilemmas.
• Delayed treatment for either condition can lead to severe morbidity, disability, or death.

Purpose of the Study:

• To review the existing literature on the management of simultaneous acute cardio-cerebral infarction (CCI).
• To identify and highlight the challenges associated with managing concurrent AIS and AMI.

Main Methods:

• Literature review of existing studies and documented cases on managing simultaneous AIS and AMI.
• Analysis of potential therapeutic conflicts between AIS and AMI treatments, such as anticoagulation and thrombolysis risks.

Main Results:

• The concurrent management of AIS and AMI is not well-defined, lacking evidence-based guidelines.
• Standard treatments for AMI (antiplatelets, anticoagulants) may increase risks like hemorrhagic conversion in AIS.
• AIS treatments (thrombolysis) can elevate risks such as cardiac wall rupture in AMI.

Conclusions:

• Optimal management strategies for cardio-cerebral infarction (CCI) remain unclear due to conflicting treatment risks.
• Further clinical studies and evidence-based guidelines are critically needed to address this rare but severe co-occurrence.